External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the CUETO Group

Clinical trial NCT05864599 · UNKNOWN

Trial details

NCT number: NCT05864599
Sponsor: Pharmalink
Status: UNKNOWN
Study type: OBSERVATIONAL

Non-muscle-invasive Bladder Cancer

Start date: 2023-06-16
Primary completion: 2024-05-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.